DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Zalcman G, Mazieres J, Margery J. et al.
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Lancet 2016;
387: 1405-1414
DOI: 10.1016/S0140-6736(15)01238-6.
We do not assume any responsibility for the contents of the web pages of other providers.